SCHEMBL7884237

SCHEMBL7884237

CN(C)Cc1cccc(Oc2ccc3cc(C(=O)N(C)C(=N)N)[nH]c3c2)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
RXFP1 Q9HBX9 2/20 0.52
ROCK2 O75116 4/20 0.47
ROCK1 Q13464 4/20 0.47
F10 P00742 2/20 0.45
F2 P00734 1/20 0.45
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ATM Q13315 1/20 0.39
PARP1 P09874 1/20 0.38
AR P10275 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT3 P36888 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873334 0.92 KMT2A (0.50) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7877497 0.91 KMT2A (0.50) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7877889 0.88 MEN1 (0.50) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7877806 0.88 KMT2A (0.45) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7882065 0.86 KMT2A (0.53) MEN1KMT2ARXFP1F10NPC1
SCHEMBL7877882 0.85 KMT2A (0.45) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7881184 0.85 KMT2A (0.47) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7881140 0.85 RXFP1 (0.45) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7884561 0.85 MEN1 (0.44) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7881478 0.85 PPARG (0.40) MEN1KMT2ARXFP1ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed